341 related articles for article (PubMed ID: 29072955)
21. Prospective Trial Using Internal Pair-Production Positron Emission Tomography to Establish the Yttrium-90 Radioembolization Dose Required for Response of Hepatocellular Carcinoma.
Chan KT; Alessio AM; Johnson GE; Vaidya S; Kwan SW; Monsky W; Wilson AE; Lewis DH; Padia SA
Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):358-365. PubMed ID: 29559288
[TBL] [Abstract][Full Text] [Related]
22. Microsphere localization and dose quantification using positron emission tomography/CT following hepatic intraarterial radioembolization with yttrium-90 in patients with advanced hepatocellular carcinoma.
Lea WB; Tapp KN; Tann M; Hutchins GD; Fletcher JW; Johnson MS
J Vasc Interv Radiol; 2014 Oct; 25(10):1595-603. PubMed ID: 25156647
[TBL] [Abstract][Full Text] [Related]
23. Survival benefit of radioembolization for inoperable hepatocellular carcinoma using yttrium-90 microspheres.
Kwok PC; Leung KC; Cheung MT; Lam TW; Szeto LT; Chou SQ; Chia NH; Tong CM; Yuen PK; Cheung CH; Law CK
J Gastroenterol Hepatol; 2014 Nov; 29(11):1897-904. PubMed ID: 24734957
[TBL] [Abstract][Full Text] [Related]
24. Same-Day Yttrium-90 Radioembolization: Feasibility with Resin Microspheres.
Li MD; Chu KF; DePietro A; Wu V; Wehrenberg-Klee E; Zurkiya O; Liu RW; Ganguli S
J Vasc Interv Radiol; 2019 Mar; 30(3):314-319. PubMed ID: 30819470
[TBL] [Abstract][Full Text] [Related]
25. Yttrium-90 Radioembolization for Hepatocellular Carcinoma.
Hickey RM; Lewandowski RJ; Salem R
Semin Nucl Med; 2016 Mar; 46(2):105-8. PubMed ID: 26897714
[TBL] [Abstract][Full Text] [Related]
26. Radiologic-pathologic correlation of hepatocellular carcinoma treated with internal radiation using yttrium-90 microspheres.
Riaz A; Kulik L; Lewandowski RJ; Ryu RK; Giakoumis Spear G; Mulcahy MF; Abecassis M; Baker T; Gates V; Nayar R; Miller FH; Sato KT; Omary RA; Salem R
Hepatology; 2009 Apr; 49(4):1185-93. PubMed ID: 19133645
[TBL] [Abstract][Full Text] [Related]
27. Positron emission tomography/CT after yttrium-90 radioembolization: current and future applications.
Gates VL; Salem R; Lewandowski RJ
J Vasc Interv Radiol; 2013 Aug; 24(8):1153-5. PubMed ID: 23885913
[No Abstract] [Full Text] [Related]
28. Assessment of Hepatocellular Carcinoma Response to
Hectors SJ; Lewis S; Kennedy P; Bane O; Said D; Segall M; Schwartz M; Kim E; Taouli B
Radiol Imaging Cancer; 2020 Jul; 2(4):e190094. PubMed ID: 32803165
[TBL] [Abstract][Full Text] [Related]
29. Demonstration of therapy response to radioembolization with
Ozkan E; Demir B; Oz DK; Soydal C; Dursun E; Celebioglu EC; Idilman R; Kucuk NO
Eur J Nucl Med Mol Imaging; 2023 Dec; 51(1):316-317. PubMed ID: 37632564
[No Abstract] [Full Text] [Related]
30. How to Prepare a Patient for Transarterial Radioembolization? A Practical Guide.
Denys A; Pracht M; Duran R; Guiu B; Adib S; Boubaker A; Bize P
Cardiovasc Intervent Radiol; 2015 Aug; 38(4):794-805. PubMed ID: 25828724
[TBL] [Abstract][Full Text] [Related]
31. Usefulness of radioembolization in identifying patients with favorable tumor biology before living donor liver transplantation.
Yu YD; Kim DS; Jung SW; Kim Y; Suh SO
Transplantation; 2014 Sep; 98(5):e47-50. PubMed ID: 25171535
[No Abstract] [Full Text] [Related]
32. SPECT/CT with 99mTc-MAA in radioembolization with 90Y microspheres in patients with hepatocellular cancer.
Hamami ME; Poeppel TD; Müller S; Heusner T; Bockisch A; Hilgard P; Antoch G
J Nucl Med; 2009 May; 50(5):688-92. PubMed ID: 19372479
[TBL] [Abstract][Full Text] [Related]
33. Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma.
Kooby DA; Egnatashvili V; Srinivasan S; Chamsuddin A; Delman KA; Kauh J; Staley CA; Kim HS
J Vasc Interv Radiol; 2010 Feb; 21(2):224-30. PubMed ID: 20022765
[TBL] [Abstract][Full Text] [Related]
34. Cholecystoduodenal fistula after yttrium-90 radioembolization.
Patel NM; Yuan J; David J
J Clin Gastroenterol; 2010 Sep; 44(8):594-5. PubMed ID: 20216427
[No Abstract] [Full Text] [Related]
35. Treatment response assessment following transarterial radioembolization for hepatocellular carcinoma.
Alem Z; Murray TE; Egri C; Chung J; Liu D; Elsayes KM; Chang SD; Harris A
Abdom Radiol (NY); 2021 Aug; 46(8):3596-3614. PubMed ID: 33909092
[TBL] [Abstract][Full Text] [Related]
36. Survival in patients with hepatocellular carcinoma treated with 90Y-microsphere radioembolization. Prediction by 18F-FDG PET.
Sabet A; Ahmadzadehfar H; Bruhman J; Sabet A; Meyer C; Wasmuth JC; Pieper CC; Biersack HJ; Ezziddin S
Nuklearmedizin; 2014; 53(2):39-45. PubMed ID: 24777354
[TBL] [Abstract][Full Text] [Related]
37. Outcomes of Yttrium-90 Radioembolization for Unresectable Combined Biphenotypic Hepatocellular-Cholangiocarcinoma.
Malone CD; Gibby W; Tsai R; Kim SK; Lancia S; Akinwande O; Ramaswamy RS
J Vasc Interv Radiol; 2020 May; 31(5):701-709. PubMed ID: 32127318
[TBL] [Abstract][Full Text] [Related]
38. Histogram Analysis of CT Perfusion of Hepatocellular Carcinoma for Predicting Response to Transarterial Radioembolization: Value of Tumor Heterogeneity Assessment.
Reiner CS; Gordic S; Puippe G; Morsbach F; Wurnig M; Schaefer N; Veit-Haibach P; Pfammatter T; Alkadhi H
Cardiovasc Intervent Radiol; 2016 Mar; 39(3):400-8. PubMed ID: 26216725
[TBL] [Abstract][Full Text] [Related]
39.
Jreige M; Mitsakis P; Van Der Gucht A; Pomoni A; Silva-Monteiro M; Gnesin S; Boubaker A; Nicod-Lalonde M; Duran R; Prior JO; Denys A; Schaefer N
Eur J Nucl Med Mol Imaging; 2017 Jul; 44(7):1215-1222. PubMed ID: 28233086
[TBL] [Abstract][Full Text] [Related]
40. Angiosomal radiopathologic analysis of transarterial radioembolization for the treatment of hepatocellular carcinoma.
Ahmed AF; Samreen N; Grajo JR; Zendejas I; Sistrom CL; Collinsworth A; Esnakula A; Shah JL; Cabrera R; Geller BS; Toskich BB
Abdom Radiol (NY); 2018 Jul; 43(7):1825-1836. PubMed ID: 29052747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
